2019 Annual Meeting | C46 - Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder)
Program Materials Program Evaluations
07:00 AM - 07:40 AM EDT | Speaker |
Avances en el diagnóstico y terapia de las cefaleas
Ana Recober-Montilla, MD |
07:40 AM - 08:00 AM EDT | Discussion |
Sesión de preguntas y respuestas
Ana Recober-Montilla, MD |
08:00 AM - 08:40 AM EDT | Speaker |
Avances en el diagnóstico y terapia de los trastornos neuromusculares
Diana Castro, MD |
08:40 AM - 09:00 AM EDT | Discussion |
Sesión de preguntas y respuestas
Diana Castro, MD |
Dario Beltran, MD, FAAN | Dr. Beltran has nothing to disclose. |
Jose G. Merino, MD, MPhil, FAHA, FAAN | The institution of Dr. Merino has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Merino has received personal compensation in the range of $500-$4,999 for serving as a StrokeNet DSMB Member with National Institute of Neurological Disorders and Stroke. |
Ana Recober-Montilla, MD | Dr. Recober-Montilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Recober-Montilla has received intellectual property interests from a discovery or technology relating to health care. |
Diana Castro, MD | Dr. Castro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Castro has received research support from Biogen. The institution of Dr. Castro has received research support from Sarepta. The institution of Dr. Castro has received research support from Fibrogen . |